Enzo Biochem Receives Favorable Decision in Patent Litigation Case

Enzo Biochem (ENZ) Announces Favorable Judgment by U.S. Patent Office in an Interference against Bayer HealthCare for a Universal Diagnostic Detection System. The effect of this judgment is that Enzo will receive a full seventeen year patent for all the inventions covered by its claims, which term will commence on the date of issuance of the patent. – Business Wire